Is PKPH or JEPQ a better dividend investment in 2026?

PKPH currently yields 129.03% with a 5% 5-year dividend growth rate. JEPQ yields 11.10% with 5% growth. The better choice depends on your goal: PKPH offers higher current income.

What is the dividend yield difference between PKPH and JEPQ?

PKPH has a forward dividend yield of 129.03% ($2.00/share annually). JEPQ yields 11.10% ($6.16/share annually). The yield gap is 117.93 percentage points.

Home › Compare › PKPH vs JEPQ

PKPH vs JEPQ: Dividend Comparison 2026

PKPH yields 129.03% · JEPQ yields 11.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PKPH wins by $11.91M in total portfolio value

INVESTMENT

TIME HORIZON10 years

PKPH

● Live price

129.03%

Share price

$1.55

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$11.95M

Annual income

$4,733,958.72

Full PKPH calculator →

JEPQ

JPMorgan Nasdaq Equity Premium Income ETF

● Live price

11.10%

Share price

$55.52

Annual div

$6.16

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.8K

Annual income

$2,152.59

Full JEPQ calculator →

Portfolio growth — PKPH vs JEPQ

📍 PKPH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	PKPH	JEPQ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, PKPH + JEPQ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

PKPH pays

JEPQ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PKPH

Annual income on $10K today (after 15% tax)

$10,967.74/yr

After 10yr DRIP, annual income (after tax)

$4,023,864.91/yr

JEPQ

Annual income on $10K today (after 15% tax)

$943.83/yr

After 10yr DRIP, annual income (after tax)

$1,829.70/yr

At 15% tax rate, PKPH beats the other by $4,022,035.21/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PKPH + JEPQ for your $10,000?

PKPH: 50%JEPQ: 50%

100% JEPQ50/50100% PKPH

Portfolio after 10yr

$6.00M

Annual income

$2,368,055.65/yr

Blended yield

39.48%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PKPH buys

JEPQ buys

No recent congressional trades found for PKPH or JEPQ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricPKPHJEPQ

Forward yield	129.03% ✓	11.10%
Annual dividend / share	$2.00	$6.16 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$11.95M	$44.8K ✓
Annual income after 10y	$4,733,958.72 ✓	$2,152.59
Total dividends collected	$10.93M	$16.3K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: PKPH vs JEPQ ($10,000, DRIP)

Year	PKPH Portfolio	PKPH Income/yr	JEPQ Portfolio	JEPQ Income/yr	Gap
1← crossover	$23,603	$12,903.23	$11,930	$1,110.39	+$11.7K → PKPH
2	$53,719	$28,463.34	$14,133	$1,224.34	+$39.6K → PKPH
3	$118,021	$60,542.03	$16,632	$1,340.46	+$101.4K → PKPH
4	$250,593	$124,310.20	$19,454	$1,457.97	+$231.1K → PKPH
5	$514,813	$246,678.79	$22,626	$1,576.08	+$492.2K → PKPH
6	$1,024,469	$473,618.88	$26,175	$1,694.09	+$998.3K → PKPH
7	$1,977,016	$880,834.70	$30,133	$1,811.32	+$1.95M → PKPH
8	$3,704,035	$1,588,627.70	$34,531	$1,927.17	+$3.67M → PKPH
9	$6,744,972	$2,781,654.52	$39,403	$2,041.08	+$6.71M → PKPH
10	$11,951,079	$4,733,958.72	$44,787	$2,152.59	+$11.91M → PKPH

PKPH vs JEPQ: Complete Analysis 2026

PKPH — Stock

Peak Pharmaceuticals, Inc. operates as a biopharmaceutical and nutraceutical company in the United States. The company focuses to develop, manufacture, market, and sell medicinal products based on extracts from hemp. It is involved in the development of over-the-counter, THCfree, hemp based products for human market for the prevention and alleviation of symptoms associated with inflammatory and auto-immune diseases. The company was formerly known as Cannabis Therapy Corporation and changed its name to Peak Pharmaceuticals, Inc. in December 2014. Peak Pharmaceuticals, Inc. was incorporated in 2007 and is based in Scottsdale, Arizona.

Full PKPH Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →

📬

Get this PKPH vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PKPH vs SCHD PKPH vs JEPI PKPH vs O PKPH vs KO PKPH vs MAIN PKPH vs XYLD PKPH vs QYLD PKPH vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.